The integration of data science into the fabric of the medical industry is ongoing. Biotechs are unique as they typically work with very limited resources but can use data-centric approaches in the early stages of drug development, where they can impart a substantial downstream impact. However, using data science effectively depends on having a constellation of opportunities, resources, and internal champions. The chances for success are further improved by human factors and a strongly human-centric approach to engagement and solution development.
Find out how Cerevel has tackled this by establishing a data science organization early that has since permeated many organizations—beginning the process of establishing data-centric platforms, technologies, and algorithms as a kind of interstitial fluid that is reducing uncertainty in decision making and increasing efficiency.
Join this session to learn: